Maria-Manuela Răvaș
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maria-Manuela Răvaș has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Virgiliu-Mihail Prunoiu
Oncological Surgery Department, University of Medicine and Pharmacy “Carol Davila” Bucharest, 050474 Bucharest, Romania
2 shared publications Eugen Brătucu
Clinical Department No. 10, General Surgery, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
1 shared publication- Eugen Brătucu
Clinical Department No 10, General Surgery, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania
1 shared publication - Hortensia-Alina Moisă
Clinical Department No 10, General Surgery, University of Medicine and Pharmacy “Carol Davila”, 050474 Bucharest, Romania
1 shared publication - Laura-Maria Manea
Department of Pneumopthiology, National Institute of Pneumophtiology “Marius Nasta”, 050159 Bucharest, Romania
1 shared publication - Laurentiu Simion
Clinical Department No 10, General Surgery, University of Medicine and Pharmacy “Carol Davila”, 050474 Bucharest, Romania
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L in Journal of Medicine and Life
- Vol. 19 (3) , 179-186
Comparison of morbidity and mortality of abdominoperineal resection vs low anterior resection in rectal cancer
Postoperative sepsis is a serious complication of rectal cancer surgery and contributes to increased morbidity and mortality. This study aimed to identify risk factors and etiologies associated with postoperative sepsis in patients undergoing rectal surgery. A retrospective cohort study was conducted at a single center, including patients with rectal cancer who underwent surgery between November 2018 and February 2023. Tumors located <5 cm from the anal verge were treated with abdominoperineal resection (APR). Recorded variables included age, sex, surgical approach, tumor location, comorbidities (cardiovascular disease, diabetes, obesity), and loco-regional septic complications (fistula, abscess). A P value < 0.05 was considered statistically significant. A total of 226 patients underwent APR or low anterior resection (LAR). APR was associated with higher odds of early (OR = 1.84, 95% CI, 0.52–6.53; P = 0.14), late (OR = 2.75, 95% CI, 0.81–9.39; P = 0.13), and overall septic complications (OR = 2.38, 95% CI, 0.96–5.91; P = 0.06) compared with LAR; however, these differences were not statistically significant. After LAR, anastomotic leakage was the leading cause of postoperative sepsis (4.67%), including five early (7 days) fistulas. In the APR group, two patients developed late pelvic abscesses. Parastomal hernia was the most common late complication after APR. Postoperative loco-regional sepsis was more frequent in patients older than 50 years and in those with comorbidities, although no statistically significant association was observed overall. The median hospital stay was 11.7 days.
- 1 March 2026
- Published by S.C. JURNALUL PENTRU MEDICINA SI VIATA S.R.L in Journal of Medicine and Life
- Vol. 19 (3) , 179-186
Open AccessComparison of morbidity and mortality of abdominoperineal resection vs low anterior resection in rectal cancer
Postoperative sepsis is a serious complication of rectal cancer surgery and contributes to increased morbidity and mortality. This study aimed to identify risk factors and etiologies associated with postoperative sepsis in patients undergoing rectal surgery. A retrospective cohort study was conducted at a single center, including patients with rectal cancer who underwent surgery between November 2018 and February 2023. Tumors located <5 cm from the anal verge were treated with abdominoperineal resection (APR). Recorded variables included age, sex, surgical approach, tumor location, comorbidities (cardiovascular disease, diabetes, obesity), and loco-regional septic complications (fistula, abscess). A P value < 0.05 was considered statistically significant. A total of 226 patients underwent APR or low anterior resection (LAR). APR was associated with higher odds of early (OR = 1.84, 95% CI, 0.52–6.53; P = 0.14), late (OR = 2.75, 95% CI, 0.81–9.39; P = 0.13), and overall septic complications (OR = 2.38, 95% CI, 0.96–5.91; P = 0.06) compared with LAR; however, these differences were not statistically significant. After LAR, anastomotic leakage was the leading cause of postoperative sepsis (4.67%), including five early (7 days) fistulas. In the APR group, two patients developed late pelvic abscesses. Parastomal hernia was the most common late complication after APR. Postoperative loco-regional sepsis was more frequent in patients older than 50 years and in those with comorbidities, although no statistically significant association was observed overall. The median hospital stay was 11.7 days.
- Open Access
Impact of Transanal Drainage Tube Placement on Anastomosis Leakage Incidence After Rectal Cancer Surgery
Background: Anastomotic leakage (AL) following rectal cancer surgery is a significant cause of mortality and morbidity. Although transanal drainage tubes are expected to reduce the rate of AL, their preventive effect remains controversial. Aim: To evaluate whether transanal drainage tube (TAD) provides protection against AL in patients without other protective methods after low anterior resection (LAR). Methods: A retrospective cohort study was performed in patients undergoing LAR for rectal cancer between 2018 and 2023. Based on postoperative management, patients were divided into four distinct groups as follows: in TAD group, after colorectal anastomosis, a 32F silicone tube was inserted through the anus by more than 5 cm above the anastomosis. The tube was secured around the anus with a skin suture and a drainage bag was attached. The tube was removed after 3–5 days after surgery. In the non-TAD group, no transanal drainage tube and no diverting stomas, respectively, were used after the anastomosis. In the ileostomy and colostomy group a stoma was often performed as a primary measure in preventing anastomotic leakage. Clinical characteristics and postoperative complications were compared among the groups. Complications were categorized as general (eventration, seroma) or septic (fistula, abscess) and further classified as early (p-value < 0.05. Results: A total of 171 patients were included: 47 (27.5%) in the TAD group, 54 (32.2%) in the non-TAD group, 25 (14.6%) in colostomy group, and 45 (26.3%) in ileostomy group. Overall, eight patients (4.7%) developed anastomotic leakage (AL). In the non-TAD group, 3 patients experienced AL (all early); in the ileostomy group, 2 patients (1 early, 1 tardive); and in the colostomy group, 2 patients (both tardive). The TAD group had one patient with AL as a tardive complication. The incidence of early general complications was significant lower in TAD group compared with the non-TAD group (OR 0.23, 95% CI [0.06–0.85]; p = 0.004), while there was no significant difference in early septic complications between TAD and ileostomy group (p = 0.71). The incidence of tardive general complications was significantly more frequent in the ileostomy group (OR 0.10, 95% CI [0.02–0.44]; p = 0.0008) compared with TAD group. Overall, total complications were significantly lower in TAD group compared to non-TAD (OR 0.15, 95% CI [0.05–0.44]; p < 0.001), ileostomy (OR 0.20, 95% CI [0.07–0.56]; p = 0.003), and colostomy ((OR 0.46 CI [0.21–0.99]; p = 0.049) groups. Furthermore, the TAD group showed a reduction rate of AL compared to the ileostomy, colostomy, and non-TAD groups (2.12% vs. 4.4%, 8%, and 5.5%) but the incidence of AL was almost similar (p = 0.65). Conclusions: The elective use of TAD is a simple and effective protective method for the prevention of overall postoperative complications, also helping to reduce the rate of AL in patients. Nevertheless, there is limited information in the literature regarding the optimal size and material of TAD, despite these factors playing an important role in the viability and effectiveness of the method.
Open AccessImpact of Transanal Drainage Tube Placement on Anastomosis Leakage Incidence After Rectal Cancer Surgery
Background: Anastomotic leakage (AL) following rectal cancer surgery is a significant cause of mortality and morbidity. Although transanal drainage tubes are expected to reduce the rate of AL, their preventive effect remains controversial. Aim: To evaluate whether transanal drainage tube (TAD) provides protection against AL in patients without other protective methods after low anterior resection (LAR). Methods: A retrospective cohort study was performed in patients undergoing LAR for rectal cancer between 2018 and 2023. Based on postoperative management, patients were divided into four distinct groups as follows: in TAD group, after colorectal anastomosis, a 32F silicone tube was inserted through the anus by more than 5 cm above the anastomosis. The tube was secured around the anus with a skin suture and a drainage bag was attached. The tube was removed after 3–5 days after surgery. In the non-TAD group, no transanal drainage tube and no diverting stomas, respectively, were used after the anastomosis. In the ileostomy and colostomy group a stoma was often performed as a primary measure in preventing anastomotic leakage. Clinical characteristics and postoperative complications were compared among the groups. Complications were categorized as general (eventration, seroma) or septic (fistula, abscess) and further classified as early (p-value < 0.05. Results: A total of 171 patients were included: 47 (27.5%) in the TAD group, 54 (32.2%) in the non-TAD group, 25 (14.6%) in colostomy group, and 45 (26.3%) in ileostomy group. Overall, eight patients (4.7%) developed anastomotic leakage (AL). In the non-TAD group, 3 patients experienced AL (all early); in the ileostomy group, 2 patients (1 early, 1 tardive); and in the colostomy group, 2 patients (both tardive). The TAD group had one patient with AL as a tardive complication. The incidence of early general complications was significant lower in TAD group compared with the non-TAD group (OR 0.23, 95% CI [0.06–0.85]; p = 0.004), while there was no significant difference in early septic complications between TAD and ileostomy group (p = 0.71). The incidence of tardive general complications was significantly more frequent in the ileostomy group (OR 0.10, 95% CI [0.02–0.44]; p = 0.0008) compared with TAD group. Overall, total complications were significantly lower in TAD group compared to non-TAD (OR 0.15, 95% CI [0.05–0.44]; p < 0.001), ileostomy (OR 0.20, 95% CI [0.07–0.56]; p = 0.003), and colostomy ((OR 0.46 CI [0.21–0.99]; p = 0.049) groups. Furthermore, the TAD group showed a reduction rate of AL compared to the ileostomy, colostomy, and non-TAD groups (2.12% vs. 4.4%, 8%, and 5.5%) but the incidence of AL was almost similar (p = 0.65). Conclusions: The elective use of TAD is a simple and effective protective method for the prevention of overall postoperative complications, also helping to reduce the rate of AL in patients. Nevertheless, there is limited information in the literature regarding the optimal size and material of TAD, despite these factors playing an important role in the viability and effectiveness of the method.